Friday, September 11, 2026 | 03:00 AM ISTहिंदी में पढें
Ipo Review
Manipal Payment IPO: Analysts say 'subscribe' for listing gains; GMP at 10%
Manipal Payment IPO review: Analysts have recommended a 'Subscribe' rating on the issue for listing gains. The current GMP stands at 10 per cent.
Updated On : 09 Sep 2026 | 6:04 PM IST
Laurus Labs: Costly prescription
While the firm is getting into higher-margin formulations, the price asked for growth is on the higher side
 "Laurus Labs: Costly prescription")
Updated On : 06 Dec 2016 | 3:19 AM IST